Current Issues in Molecular Biology (Mar 2023)

Alteration of Mesenchymal Stem Cells Isolated from Glioblastoma Multiforme under the Influence of Photodynamic Treatment

  • Kalina Tumangelova-Yuzeir,
  • Krassimir Minkin,
  • Ivan Angelov,
  • Ekaterina Ivanova-Todorova,
  • Ekaterina Kurteva,
  • Georgi Vasilev,
  • Jeliazko Arabadjiev,
  • Petar Karazapryanov,
  • Kaloyan Gabrovski,
  • Lidia Zaharieva,
  • Tsanislava Genova,
  • Dobroslav Kyurkchiev

DOI
https://doi.org/10.3390/cimb45030169
Journal volume & issue
Vol. 45, no. 3
pp. 2580 – 2596

Abstract

Read online

The central hypothesis for the development of glioblastoma multiforme (GBM) postulates that the tumor begins its development by transforming neural stem cells into cancer stem cells (CSC). Recently, it has become clear that another kind of stem cell, the mesenchymal stem cell (MSC), plays a role in the tumor stroma. Mesenchymal stem cells, along with their typical markers, can express neural markers and are capable of neural transdifferentiation. From this perspective, it is hypothesized that MSCs can give rise to CSC. In addition, MSCs suppress the immune cells through direct contact and secretory factors. Photodynamic therapy aims to selectively accumulate a photosensitizer in neoplastic cells, forming reactive oxygen species (ROS) upon irradiation, initiating death pathways. In our experiments, MSCs from 15 glioblastomas (GB-MSC) were isolated and cultured. The cells were treated with 5-ALA and irradiated. Flow cytometry and ELISA were used to detect the marker expression and soluble-factor secretion. The MSCs’ neural markers, Nestin, Sox2, and glial fibrillary acid protein (GFAP), were down-regulated, but the expression levels of the mesenchymal markers CD73, CD90, and CD105 were retained. The GB-MSCs also reduced their expression of PD-L1 and increased their secretion of PGE2. Our results give us grounds to speculate that the photodynamic impact on GB-MSCs reduces their capacity for neural transdifferentiation.

Keywords